Literature DB >> 20117105

Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.

Vin-Cent Wu1, Chin-Chi Kuo, Hung-Wei Chang, Chia-Ti Tsai, Chien-Yu Lin, Lian-Yu Lin, Yen-Hung Lin, Shuo-Meng Wang, Kuo-How Huang, Cheng-Chung Fang, Yi-Luwn Ho, Kao-Lang Liu, Chin-Chen Chang, Shih-Chieh Chueh, Shuei-Liong Lin, Ruoh-Fang Yen, Kwan-Dun Wu.   

Abstract

BACKGROUND: A common pharmacologic test for the diagnosis of primary aldosteronism (PA) is the administration of captopril to determine whether an abnormal plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio(ARR) persists, although active renin concentration (ARC) may offer advantages with regard to processing and standardization.
METHODS: A prospective, head-to-head study was conducted between Feb 2008 and Dec 2008. One hundred and fourteen patients enrolled and received captopril to aid in the diagnosis of PA in the TAIPAI intervention.
RESULTS: Fifty-one patients were diagnosed with PA. Post-captopril ARC was significantly correlated with PRA. The area under the receiver operating characteristic curve of the post-captopril ARR was not different in PRA vs ARC measurements. When post-captopril ARC-based ARR (ARR(ARC))>35.5 as the cut-off value, we obtained sensitivity of 75.0% and specificity of 86.4% to differentiate PA from essential hypertension.
CONCLUSIONS: The correlation of individual PRA and ARC after administration of captopril was excellent; especially at the lower PRA levels. Post-captopril ARR(ARC) values used to diagnose PA are not different from post-captopril PRA-based (ARR(PRA)) values in patients without kidney, liver and heart failures. Primary aldosteronism can be diagnosed with a post-captopril cut-off value of ARR(ARC)>35.5 pmol/ng. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117105     DOI: 10.1016/j.cca.2010.01.027

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  A patient with concurrent primary aldosteronism and Page kidney.

Authors:  Chin-Chi Kuo; Huan-Lun Hsu; Chao-Yuan Huang; Kao-Lang Liu; Vin-Cent Wu; Ching-Wei Tsai; Wei-Jie Wang
Journal:  Endocrine       Date:  2010-06-24       Impact factor: 3.633

2.  Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis.

Authors:  Alexander A Leung; Christopher J Symonds; Gregory L Hundemer; Paul E Ronksley; Diane L Lorenzetti; Janice L Pasieka; Adrian Harvey; Gregory A Kline
Journal:  Hypertension       Date:  2022-06-02       Impact factor: 9.897

3.  Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism.

Authors:  Hung-Wei Liao; Shuo-Meng Wang; Chieh-Kai Chan; Yen-Hung Lin; Po-Chih Lin; Chen-Hsun Ho; Yu-Chun Liu; Jeff S Chueh; Vin-Cent Wu
Journal:  Ther Adv Chronic Dis       Date:  2020-08-27       Impact factor: 5.091

4.  The value of the post-captopril aldosterone/renin ratio for the diagnosis of primary aldosteronism and the influential factors: A meta-analysis.

Authors:  Qiao Xiang; Wen Wang; Tao Chen; Kai Yu; Qianrui Li; Tingting Zhang; Haoming Tian; Yan Ren
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

5.  Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism.

Authors:  François Corbin; Pierre Douville; Marcel Lebel
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-07-28

6.  Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population.

Authors:  Vin-Cent Wu; Kuo-How Huang; Kang-Yung Peng; Yao-Chou Tsai; Che-Hsiung Wu; Shuo-Meng Wang; Shao-Yu Yang; Lian-Yu Lin; Chin-Chen Chang; Yen-Hung Lin; Shuei-Liong Lin; Tzong-Shinn Chu; Kwan-Dun Wu
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

7.  Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans.

Authors:  Yen-Hung Lin; Chia-Hung Chou; Xue-Ming Wu; Yi-Yao Chang; Chi-Sheng Hung; Ying-Hsien Chen; Yu-Lin Tzeng; Vin-Cent Wu; Yi-Lwun Ho; Fon-Jou Hsieh; Kwan-Dun Wu
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

8.  Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: A meta-analysis.

Authors:  Xiyue Li; Richa Goswami; Shumin Yang; Qifu Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-08-17       Impact factor: 1.636

9.  Urinary sodium potassium ratio is associated with clinical success after adrenalectomy in patients with unilateral primary aldosteronism.

Authors:  Ming-Jse Lee; Chiao-Yin Sun; Ching-Chu Lu; Yuan-Shian Chang; Heng-Chih Pan; Yen-Hung Lin; Vin-Cent Wu; Jeff S Chueh
Journal:  Ther Adv Chronic Dis       Date:  2021-02-12       Impact factor: 5.091

10.  The Value of Different Single or Combined Indexes of the Captopril Challenge Test in the Diagnosis of Primary Aldosteronism.

Authors:  Qiao Xiang; Tao Chen; Kai Yu; Yuanmei Li; Qianrui Li; Haoming Tian; Yan Ren
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.